{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:27:57Z","timestamp":1794256077936,"version":"4.9.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001858","name":"VINNOVA","doi-asserted-by":"publisher","award":["2018-03350"],"award-info":[{"award-number":["2018-03350"]}],"id":[{"id":"10.13039\/501100001858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>A mismatch between a widespread use of broad-spectrum antibiotic agents and a low prevalence of reported bacterial co-infections in patients with SARS-CoV-2 infections has been observed<jats:bold>.<\/jats:bold> Herein, we sought to characterize and compare bacterial co-infections at admission in hospitalized patients with SARS-CoV-2, influenza or respiratory syncytial virus (RSV) positive community-acquired pneumonia (CAP).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective cohort study of bacterial co-infections at admission in SARS-CoV-2, influenza or RSV-positive adult patients with CAP admitted to Karolinska University Hospital in Stockholm, Sweden, from year 2011 to 2020. The prevalence of bacterial co-infections was investigated and compared between the three virus groups. In each virus group, length of stay, ICU-admission and 30-day mortality was compared in patients with and without bacterial co-infection, adjusting for age, sex and co-morbidities. In the SARS-CoV-2 group, risk factors for bacterial co-infection, were assessed using logistic regression models and creation of two scoring systems based on disease severity, age, co-morbidities and inflammatory markers with assessment of concordance statistics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Compared to influenza and RSV, the bacterial co-infection testing frequency in SARS-CoV-2 was lower for all included test modalities. Four percent [46\/1243 (95% CI 3\u20135)] of all SARS-CoV-2 patients had a bacterial co-infection at admission, whereas the proportion was 27% [209\/775 (95% CI 24\u201330)] and 29% [69\/242 (95% CI 23\u201335)] in influenza and RSV, respectively. <jats:italic>S. pneumoniae<\/jats:italic> and <jats:italic>S. aureus<\/jats:italic> constituted the most common bacterial findings for all three virus groups. Comparing SARS-CoV-2 positive patients with and without bacterial co-infection at admission, a relevant association could not be demonstrated nor excluded with regards to risk of ICU-admission (aHR 1.53, 95% CI 0.87\u20132.69) or 30-day mortality (aHR 1.28, 95% CI 0.66\u20132.46) in adjusted analyses. Bacterial co-infection was associated with increased inflammatory markers, but the diagnostic accuracy was not substantially different in a scoring system based on disease severity, age, co-morbidities and inflammatory parameters [C statistic 0.66 (95% CI 0.59\u20130.74)], compared to using disease severity, age and co-morbidities only [C statistic 0.63 (95% CI 0.56\u20130.70)].<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The prevalence of bacterial co-infections was significantly lower in patients with community-acquired SARS-CoV-2 positive pneumonia as compared to influenza and RSV positive pneumonia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07089-9","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T14:03:00Z","timestamp":1643637780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus"],"prefix":"10.1186","volume":"22","author":[{"given":"Pontus","family":"Hedberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niclas","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Ternhag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Abdel-Halim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Hedlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pontus","family":"Naucl\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,31]]},"reference":[{"issue":"9400","key":"7089_CR1","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/S0140-6736(03)15021-0","volume":"362","author":"TM File","year":"2003","unstructured":"File TM. Community-acquired pneumonia. Lancet (London, England). 2003;362(9400):1991\u20132001.","journal-title":"Lancet (London, England)"},{"issue":"2","key":"7089_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1164\/ajrccm.160.2.9808045","volume":"160","author":"M Ruiz","year":"1999","unstructured":"Ruiz M, Ewig S, Marcos MA, et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Resp Crit Care Med. 1999;160(2):397\u2013405.","journal-title":"Am J Resp Crit Care Med."},{"issue":"3","key":"7089_CR3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1128\/CMR.00058-05","volume":"19","author":"JA McCullers","year":"2006","unstructured":"McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev. 2006;19(3):571\u201382.","journal-title":"Clin Microbiol Rev"},{"issue":"9773","key":"7089_CR4","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/S0140-6736(10)61459-6","volume":"377","author":"O Ruuskanen","year":"2011","unstructured":"Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet (London, England). 2011;377(9773):1264\u201375.","journal-title":"Lancet (London, England)"},{"issue":"1","key":"7089_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.diagmicrobio.2018.11.014","volume":"94","author":"YK Lim","year":"2019","unstructured":"Lim YK, Kweon OJ, Kim HR, Kim T-H, Lee M-K. Impact of bacterial and viral coinfection in community-acquired pneumonia in adults. Diagn Microbiol Infect Dis. 2019;94(1):50\u20134.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"7089_CR6","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s10096-020-03874-z","volume":"39","author":"H Ge","year":"2020","unstructured":"Ge H, Wang X, Yuan X, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020;39(6):1011\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"7089_CR7","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.cmi.2020.06.025","volume":"26","author":"S Hughes","year":"2020","unstructured":"Hughes S, Troise O, Donaldson H, Mughal N, Moore LSP. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect. 2020;26(10):1395\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"7089_CR8","first-page":"2459","volume":"71","author":"TM Rawson","year":"2020","unstructured":"Rawson TM, Moore LSP, Zhu N, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71(9):2459\u201368.","journal-title":"Clin Infect Dis"},{"key":"7089_CR9","doi-asserted-by":"publisher","first-page":"198005","DOI":"10.1016\/j.virusres.2020.198005","volume":"285","author":"X Zhu","year":"2020","unstructured":"Zhu X, Ge Y, Wu T, et al. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res. 2020;285:198005.","journal-title":"Virus Res"},{"issue":"1","key":"7089_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cmi.2020.07.041","volume":"27","author":"C Garcia-Vidal","year":"2021","unstructured":"Garcia-Vidal C, Sanjuan G, Moreno-Garc\u00eda E, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021;27(1):83\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"7089_CR11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","volume":"81","author":"L Lansbury","year":"2020","unstructured":"Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266\u2013275. https:\/\/doi.org\/10.1016\/j.jinf.2020.05.046.","journal-title":"SSRN Electronic J."},{"issue":"12","key":"7089_CR12","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","volume":"26","author":"BJ Langford","year":"2020","unstructured":"Langford BJ, So M, Raybardhan S, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26(12):1622\u20139. https:\/\/doi.org\/10.1016\/j.cmi.2020.07.016.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"7089_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-05902-5","volume":"21","author":"JM Thelen","year":"2021","unstructured":"Thelen JM, Buenen AG, van Apeldoorn M, Wertheim HF, Hermans MHA, Wever PC. Community-acquired bacteraemia in COVID-19 in comparison to influenza A and influenza B: a retrospective cohort study. BMC Infect Dis. 2021;21(1):1\u20137.","journal-title":"BMC Infect Dis."},{"issue":"5","key":"7089_CR14","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1093\/jac\/dkaa563","volume":"76","author":"CY Mason","year":"2021","unstructured":"Mason CY, Kanitkar T, Richardson CJ, Lanzman M, Stone Z, Mahungu T, Mack D, Wey EQ, Lamb L, Balakrishnan I, Pollara G. Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics. J Antimicrob Chemother. 2021;76(5):1323-1331. https:\/\/doi.org\/10.1093\/jac\/dkaa563.","journal-title":"J Antimicrob Chemotherapy"},{"key":"7089_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jhin.2021.01.006","volume":"110","author":"EJ Williams","year":"2021","unstructured":"Williams EJ, Mair L, de Silva TI, et al. Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-CoV-2 infection: a retrospective cohort study. J Hosp Infect. 2021;110:103\u20137.","journal-title":"J Hosp Infect"},{"issue":"3","key":"7089_CR16","doi-asserted-by":"publisher","first-page":"E47","DOI":"10.7861\/clinmed.Let.20.3.3","volume":"20","author":"J Han","year":"2020","unstructured":"Han J, Gatheral T, Williams C. Procalcitonin for patient stratification and identification of bacterial co-infection in COVID-19. Clin Med. 2020;20(3):E47.","journal-title":"Clin Med"},{"key":"7089_CR17","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/BF02019941","volume":"1","author":"M Kalin","year":"1982","unstructured":"Kalin M. Bacteremic pneumococcal pneumonia: value of culture of nasopharyngeal specimens and examination of washed sputum specimens. European J Clin Microbiol. 1982;1:394\u20136.","journal-title":"European J Clin Microbiol."},{"issue":"5","key":"7089_CR18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/BF01647005","volume":"18","author":"J Hedlund","year":"1990","unstructured":"Hedlund J, Ortqvist A, Kalin M. Nasopharyngeal culture in the pneumonia diagnosis. Infection. 1990;18(5):283\u20135.","journal-title":"Infection."},{"key":"7089_CR19","unstructured":"Petersson J, Kalin M, Giske CG. Kvantitativa odlingar fr\u00e5n nedre luftv\u00e4garna och hur de ska tolkas. L\u00e4kartidningen. 2009; (34)."},{"issue":"2","key":"7089_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0732-8893(02)00484-4","volume":"45","author":"M Welti","year":"2003","unstructured":"Welti M, Jaton K, Altwegg M, Sahli R, Wenger A, Bille J. Development of a multiplex real-time quantitative PCR assay to detect Chlamydia pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae in respiratory tract secretions. Diagn Microbiol Infect Dis. 2003;45(2):85\u201395.","journal-title":"Diagn Microbiol Infect Dis."},{"issue":"2","key":"7089_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1086\/648678","volume":"50","author":"N Johansson","year":"2010","unstructured":"Johansson N, Kalin M, Tiveljung-Lindell A, Giske CG, Hedlund J. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis. 2010;50(2):202\u20139.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07089-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07089-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07089-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T14:03:41Z","timestamp":1643637821000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07089-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7089"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07089-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,31]]},"assertion":[{"value":"28 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Swedish Ethical Review Authority (Dnr 2018\/1030-31, COVID-19 research amendment Dnr 2020-01385). All methods were performed in accordance with the relevant guidelines and regulations as stated in the Declarations of Helsinki. The need for consent was waived by the Swedish Ethical Review Authority (Dnr 2018\/1030-31, COVID-19 research amendment Dnr 2020-01385) since analyses are based on retrospectively collected data from the electronic health record system.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors report competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}